1. Home
  2. RDZN vs ICCC Comparison

RDZN vs ICCC Comparison

Compare RDZN & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roadzen Inc.

RDZN

Roadzen Inc.

N/A

Current Price

$0.98

Market Cap

87.7M

Sector

Finance

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$10.75

Market Cap

88.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RDZN
ICCC
Founded
2015
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.7M
88.9M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
RDZN
ICCC
Price
$0.98
$10.75
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $5.00
N/A
AVG Volume (30 Days)
★ 260.2K
5.1K
Earning Date
11-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 72.12
53.85
EPS
N/A
★ 0.51
Revenue
★ $55,021,792.00
$26,493,169.00
Revenue This Year
$41.04
N/A
Revenue Next Year
$78.38
N/A
P/E Ratio
★ N/A
$24.88
Revenue Growth
24.21
★ 51.64
52 Week Low
$0.98
$4.52
52 Week High
$2.56
$12.10

Technical Indicators

Market Signals
Indicator
RDZN
ICCC
Relative Strength Index (RSI) 36.83 59.76
Support Level N/A $9.47
Resistance Level $1.44 $10.76
Average True Range (ATR) 0.09 0.31
MACD -0.01 0.01
Stochastic Oscillator 11.64 94.26

Price Performance

Historical Comparison
RDZN
ICCC

About RDZN Roadzen Inc.

Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express. Geographically, the company operates in India, United States of America, United Kingdom, and China. It generates maximum revenue form India.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: